Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma
Stealthy Flagship cancer drug startup nabs $21M, new Kendall Square digs
Science Exchange Signs on as LabCentral Sponsor to Support Life Science and Biotech Startups with Outsourced R&D Services